[Clinical and experimental studies in the treatment of chronic granulocytic leukemia with indirubin (author's transl)].
D000293:Adolescent; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007211:Indoles / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000276:immunology / Q000648:ultrastructure; D008297:Male; D008516:Medicine, Chinese Traditional; D008518:Medicine, East Asian Traditional; D051379:Mice; D008875:Middle Aged; D051381:Rats
D000970:Antineoplastic Agents; D007211:Indoles; C027185:indirubin